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Abstract: The chemical investigation of an Indonesian specimen of Theonella swinhoei 
afforded four aurantosides, one of which, aurantoside J (5), is a new compound. The 
structure of this metabolite, exhibiting the unprecedented N-α-glycosidic linkage between 
the pentose and the tetramate units, has been determined through detailed spectroscopic 
analysis. The four obtained aurantosides have been tested against five fungal strains   
(four Candida and one Fusarium) responsible of invasive infections in immuno-compromised 
patients. The non-cytotoxic aurantoside I (4) was the single compound to show an excellent 
potency against all the tested strains, thus providing valuable insights about the antifungal 
potential of this class of compounds and the structure-activity relationships.  
OPEN ACCESSMar. Drugs 2011, 9  
 
 
2810
Keywords: Theonella swhinoei; aurantosides; N-glycosides; antifungal activity 
 
1. Introduction  
Aurantosides and rubrosides are orange-red pigments isolated from sponges of the genera 
Theonella, Homophymia and Siliquariaspongia, all belonging to the order Lithistida [1–5]. These 
complex molecules include three different structural moieties: a mono- or dichlorinated long (C18 to C28) 
conjugated polyene chain (terminating with an oxygenated five-membered ring in the rubroside 
subfamily), a tetramate ring, and an N-glycosidic moiety made up by one to three monosaccharide 
units, which are, invariably, pentose or deoxypentose sugars. 
Compared to non-ribosomial cyclic and linear peptides and to polyketide macrolides, the most 
widely investigated secondary metabolites from sponges of the Lithistida order, aurantosides have 
been largely overlooked, also in terms of their biomedical potential. The reasons for this observation 
can be mostly found in the difficulties associated to their isolation in the pure form and to their relative 
instability, which is obviously related to the presence of the polyene moiety. 
In the frame of our ongoing investigation of Indonesian invertebrates for bioactive secondary 
metabolites [6–8], we have recently analyzed a specimen of Theonella swinhoei (Theonellidae, 
Lithistida) and reported the isolation of dehydroconicasterol and of aurantoic acid (1) [9].
 This latter 
compound closely resembles the polyene moiety of aurantosides G–I [4], although the biosynthetic 
relationship between aurantoic acid and aurantosides has not been established. Chemical analysis of 
the most polar fractions of the organic extract obtained from the same organism revealed that they 
were practically devoid of polar polypeptides or macrolides, while they contained consistent amounts 
of aurantosides. In this paper we describe the isolation and the structure elucidation of the three known 
aurantosides G–I (2–4) and of the new aurantoside J (5) from these fractions (see Scheme 1). In 
addition, we report the results of a detailed investigation of the antifungal activity of the isolated 
aurantosides, which revealed a strict dependency from the glycosylation pattern.  
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2. Results and Discussion  
A specimen of the sponge T. swinhoei was collected by hand in the area of the Bunaken Marine 
Park of Manado (North Sulawesi, Indonesia) and kept frozen until sequentially extracted with MeOH 
and CH2Cl2 by soaking the sliced sponge tissues (560 g wet wt). The extracts were combined, 
concentrated and partitioned between EtOAc and H2O. Then, the water-soluble fraction was 
partitioned against n-BuOH and the so obtained polar organic extract (3.8 g) was chromatographed on 
a C18 reversed-phase silica gel column, using a gradient solvent system going from H2O/MeOH 7:3 to 
H2O/MeOH 1:9. Repeated RP18 HPLC purifications (H2O/CH3CN mixtures, with 0.05% TFA, as 
eluents) afforded aurantosides G (2, 25.5 mg), H (3, 12.8 mg), I (4, 15.6 mg) and the new aurantoside J 
(5, 8.3 mg) in the pure form. The structures of the known aurantosides G–I (2–4) were identified on the 
basis of the comparison of their spectral data with those reported in the literature [4].
 It is worth noting 
that all the aurantosides isolated during this work showed the same length and constitution of the polyene 
side chain, while aurantosides with longer and/or dichlorinated polyene chain (as aurantosides A–F) 
were not detected in our sample. 
Aurantoside J (5) was isolated as an orange-red amorphous solid. Its ESI mass spectrum (positive 
ions) showed pseudomolecular ion peaks at m/z 517 and 519 [M + Na]
+ in the ratio of about 3:1, 
suggesting the presence of a chlorine atom. High resolution measurements (see Experimental Section) 
assigned the molecular formula C23H27ClN2O8 to 5, in accordance with the presence of eleven 
unsaturation degrees.  
The 
1H NMR spectrum (700 MHz, CD3OD) of 5 revealed the presence of a polyene unit   
(nine multiplets from δH 6.30 to 7.63), of an allylic methyl group (δH 2.21), and of a tetramic acid 
glycoside, classifying compound 5 as a metabolite of the aurantoside family. All the proton signals 
were associated to those of the directly attached carbon atoms through the 2D HSQC experiment and 
the so obtained sets of 
1H and 
13C NMR data of 5 evidenced a close resemblance with parallel data 
reported for aurantoside G (2) [4], which also shared the same molecular formula of 5.  
Combined inspection of COSY and TOCSY spectra allowed a deconvolution of the proton signals 
within the polyene moiety and the consequent assignment of the proton and carbon resonances, as well 
as of proton-proton coupling constants, within this spin system. The obtained data appeared in 
excellent agreement with those reported for aurantoside G, suggesting that 2 and 5 should share this 
part of their structures, including the all-trans geometry of the disubstituted double bonds. The   
Z geometry of the terminal, chlorine-bearing double bond, was secured on the basis of the ROESY 
cross-peak between the methyl singlet at δ 2.21 (Me-18) and the doublet at δ 6.30 (H-16).  
The identification of the stereostructure of the tetramate moiety, as well as its attachment to the 
polyene chain, was largely based on the comparison with literature data. The HMBC spectrum 
(Figure 1) showed cross-peaks of the methine resonating at δ 4.18 (H-4) with C-1, C-2, C-3 and with 
the amide carbon at 174.1, while the doublet at δ 7.23 (H-8) showed cross-peaks with C-7 and C-2. 
This pattern of HMBC correlations and the consequent assignment of 
13C NMR resonances were in 
perfect agreement with values reported for other aurantosides. In accordance with the behavior 
reported for aurantosides and for other tetramic acid derivatives [10], the keto-enol tautomerization of 
the adjoining tetramic acid portion of the molecule caused the appearance of a couple of small methine Mar. Drugs 2011, 9  
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resonances (ratio 1:3 compared to other methine signals) in the sp
2 region of the 
1H NMR spectrum of 5, 
which are most likely attributable to H-8 and H-9 on the minor tautomer.  
Figure 1. Key H→C HMBC correlations detected for aurantoside J. 
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The spin system of a pentose monosaccharide was easily identified from the COSY spectrum. The 
HMBC correlation of the anomeric proton (δH 5.01, δC 82.9) with C-1 and C-4, as well as its relatively 
high-field resonance, defined its attachment to the nitrogen atom of the tetramate ring, while the 
HMBC correlation H-1′/C-5′ indicated its pyranose form. The large value of the 
3J scalar coupling 
constants  JH-2′/H-3′ and JH-3′/H-4′ (=10.2 Hz) and the small value of JH-1′/H-2′ (=2.6 Hz) allowed the 
identification of this sugar as a α-xylopyranose and strongly suggested the conformation depicted in 
Scheme 1. Of course, the predominance of different conformations in different solvents cannot be 
excluded. Given the small amount of compound available (largely used for evaluation of cytotoxic and 
antifungal activities, see below), the absolute configuration of the xylopyranosyl unit in 5 was not 
determined. However, a D configuration could be confidently assigned to this sugar, considering that 
the xylose units present in all the aurantosides isolated to date, including 2–4, invariably proved to 
belong to the D series. 
In conclusion, aurantoside J (5) is a new secondary metabolite whose structure differs from that of 
the known aurantoside G (2) for the configuration at the anomeric carbon C-1′ of the xylose unit. In 
this regard, it is worth noting that aurantoside J represents the first member of this class of compounds 
to show an N-glycosidic linkage with the α-configuration.  
All the members of the aurantoside family had been evaluated for their cytotoxic activity and data 
available in the literature [1–4] clearly suggest a close relationship between the length of the polyene 
chain and the toxicity against human cell lines: an increase in the length of the chain is associated to an 
increase of the cytotoxic activity. Accordingly, aurantosides G–I (C18) and aurantosides A–B (C20) are 
not cytotoxic, aurantosides D and E (C22) are moderately cytotoxic, while aurantoside F (C24) is 
strongly cytotoxic. In perfect agreement with this trend, the new aurantoside J (5) proved to be devoid 
of any cytotoxic activity (IC50 > 70 μM) against several human cell lines (data not shown). 
Since the antifungal potential of aurantosides has remained practically undisclosed (with the single 
exception of the good antifungal activity against Aspergillus fumigatus reported for aurantosides A  
and B
3), and given the increasing need for new active agents to face fungal infections, we decided to 
evaluate aurantosides G–J (2–5) for their antifungal activity against Fusarium solani and four Candida 
species. These strains have been selected since, together with Zygomycetes, they represent the main 
responsible of invasive fungal infections (IFIs), an increasingly important clinical dilemma, which 
engenders high rates of morbidity and mortality, particularly in immuno-compromised populations. In Mar. Drugs 2011, 9  
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the management of patients with haematological malignancies or transplant recipients, an increase in 
the incidence of fungal diseases due to opportunistic infections of genera Candida and Fusarium is 
commonly observed [11]. Unfortunately, despite an antifungal treatment with available agents, the 
mortality rate of patients with IFIs remains extremely high. Candida infections are the most frequent 
cause of IFIs worldwide and, in USA, Candida species are the fourth most common cause of 
nosocomial blood stream infection [12]. Among the 50 species of Fusarium identified to date, 
F. solani is responsible of 50% of pathogenic infections in humans [13], which are life-threatening in 
immunocompromised hosts: recognized risk factors are skin lesions, use of corticosteroids, prolonged 
neutropenia and hematological malignancy [14].  
The antifungal activity of aurantosides G–J (2–5) has been expressed as the Minimum Inhibitory 
Concentrations (MICs) and Minimum Fungicidal Concentrations (MFCs) for 90% and 50% of isolates. 
The MICs and MFCs of the four aurantosides against 15 clinical isolates of fungi (12 isolates for the 
four  Candida species C. albicans, C. parapsilosis, C. glabrata, C. tropicalis and 3 isolates for 
F. solani) are shown in Table 1. 
Table 1. In vitro activities of Aurantosides G–J against Candida spp. and F. solani 
a. 
Isolate 
b 
Aurantoside G 
MIC50/MIC90 
(MFC50/MFC90) 
in µg/mL 
Aurantoside H 
MIC50/MIC90 
(MFC50/MFC90) 
in µg/mL 
Aurantoside I 
MIC50/MIC90 
(MFC50/MFC90) 
in µg/mL 
Aurantoside J 
MIC50/MIC90 
(MFC50/MFC90) 
in µg/mL 
C. albicans   4/8 
(4/8) 
>16/>16 
(>16/>16) 
0.25/0.5 
(0.25/0.5) 
>16/>16 
(>16/>16) 
C. parapsiolsis 2/4 
(4/4) 
>16/>16 
(>16/>16) 
0.5/0.5 
(0.5/0.5) 
>16/>16 
(>16/>16) 
C. glabrata  4/8 
(8/8) 
>16/>16 
(>16/>16) 
0.125/0.125 
(0.125/0.125) 
>16/>16 
(>16/>16) 
C tropicalis  2/4 
(2/4) 
>16/>16 
(>16/>16) 
0.25/0.5 
(0.5/0.5) 
>16/>16 
(>16/>16) 
F. solani  16/>16 
(16/>16) 
>16/>16 
(>16/>16) 
1/2 
(2/2) 
>16/>16 
(>16/>16) 
a By the CLSI M27-A2 and M38-A procedure; 
b Three isolates of each species were tested. 
Only aurantosides G (2) and I (4) showed a detectable antifungal activity, but the activity of 
aurantoside G was only moderate-poor, with a MIC90 of 4–16 μg/mL against all the strains. In contrast, 
aurantoside I exhibited a very good antifungal effect against all the tested strains, especially against 
C. albicans, C. glabrata and C. tropicalis.  The activity of aurantoside I against F. solani is also 
remarkable, given the high pathogenicity of this strain and the need of potent inhibitory agents. For the 
majority of isolates, MFCs of the test compounds were either the same as or one to two dilutions 
higher than the MICs. 
The mechanism of the antifungal action of aurantoside I (4) has not been investigated; however, it 
could be related to the mechanism of other polyene antifungal agents as nystatin. Since all the 
compounds tested in this study are homogeneous in terms of the C18 polyene chain, the role of the 
sugar moiety in the modulation of the activity can be highlighted. Clearly, a trisaccharide moiety, Mar. Drugs 2011, 9  
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present in aurantoside I and in the previously reported aurantosides A–B, is needed for the antifungal 
activity of this class of compounds.  
3. Experimental Section  
3.1. General Experimental Procedures 
Optical rotations (CHCl3) were measured at 589 nm on a P2000 Jasco polarimeter using a 10 cm 
microcell. 
1H (700 MHz) and 
13C (175 MHz) NMR spectra were measured on a Varian INOVA 
spectrometer. Chemical shifts were referenced to the residual solvent signal (CD3OD: δH 3.34, δC 49.0). 
Homonuclear 
1H connectivities were determined by the COSY experiment; one-bond heteronuclear 
1H-
13C connectivities by the HSQC experiment; two- and three-bond 
1H-
13C connectivities by 
gradient-HMBC experiments optimized for a 
2,3J of 8 Hz. Low- and high-resolution ESIMS spectra 
were obtained on a LTQ OrbitrapXL (Thermo Scientific) mass spectrometer. Medium pressure liquid 
chromatography was performed on a Büchi apparatus using a silica gel (230–400 mesh) column; 
HPLC was achieved on a Knauer apparatus equipped with a refractive index detector and analytical 
LUNA (Phenomenex) RP18 (250 × 4 mm) columns. 
3.2. Animal Material, Extraction and Isolation 
A specimen of Theonella swinhoei (order Lithistida, family Theonellidae) was collected in January 
2008 along the coasts of the Bunaken Island in the Bunaken Marine Park (North Sulawesi, Indonesia). 
The species is very common in this area, from 20 to 50 m depth, on substrata subjected to strong 
currents. In vivo, the sponge is red-orange but specimens living in shadow habitats are pale pink to 
white. A voucher sample has been deposited at the Dipartimento di Chimica delle Sostanze Naturali, 
Università di Napoli Federico II (Man08-02). After homogenization, the organism (wet weight 560.2 g) 
was exhaustively extracted, in sequence, with MeOH and CH2Cl2.  The combined extracts were 
partitioned between H2O and EtOAc and, then, the water-soluble fraction was partitioned against   
n-BuOH. The obtained polar organic extract (3.8 g) was subjected to medium pressure liquid 
chromatography over a C18 reversed-phase silica gel column, using a gradient solvent system going 
from H2O/MeOH 7:3 to H2O/MeOH 1:9. Fractions eluted with H2O/MeOH 6:4 and 1:1 were 
combined and subjected to HPLC purification on RP18 column (H2O/CH3CN 65:35, with 0.05% TFA, 
as eluent) to yield aurantoside I (4, 15.6 mg) in the pure form. Fractions eluted with H2O/MeOH 4:6 
were combined and subjected to HPLC purification on RP18 column (H2O/CH3CN 35:65, with 0.05% 
TFA, as eluent) to yield aurantoside H (3, 12.8 mg) in the pure form. Fractions eluted with H2O/MeOH 
3:7 and 2:8 were combined and subjected to HPLC purification on RP18 column (H2O/CH3CN 1:1, 
with 0.05% TFA, as eluent) to yield aurantoside G (2, 25.5 mg) and the new aurantoside J (5, 8.3 mg) 
in the pure form. 
3.3. Aurantoside J (5)  
Orange amorphous solid; [α]D
25 −122 (c 0.1 in MeOH); 
1H NMR (CD3OD, 700 MHz): δH 7.63 (dd, 
J = 15.3, 11.0 Hz, H-9), 7.23 (d, J = 15.3 Hz, H-8), 6.87 (dd, J = 15.0, 11.0 Hz, H-11), 6.68 (dd,  
J = 15.0, 11.0 Hz, H-15), 6.64 (dd, J = 15.0, 11.0 Hz, H-13), 6.55 (dd, J = 15.0, 11.0 Hz, H-10),  Mar. Drugs 2011, 9  
 
 
2815
6.48 (overlapped, H-12, H-14), 6.30 (d, J = 11.0 Hz, H-16), 5.01 (d, J = 2.6 Hz, H-1′), 4.18 (bs, H-4), 
2.78 (m, H-5a), 3.83 (dd, J = 11.5, 4.5 Hz, H-5′a), 3.77 (dd, J = 10.2, 2.6 Hz, H-2′), 3.58 (m, H-4′), 
3.36 (t, J = 10.2 Hz, H-3′), 3.22 (dd, J = 11.5, 9.5 Hz, H-5′b), 2.68 (m, H-5b), 2.21 (s, Me-18);  
13C NMR (CD3OD, 175 MHz): δ 201.7 (s, C-3), 175.7 (s, C-1), 175.2 (s, C-7), 174.1 (s, C-6),   
145.5 (d, C-11), 144.4 (d, C-9), 141.0 (d, C-13), 134.5 (d, C-12), 134.3 (d, C-14), 134.0 (s, C-17), 
133.0 (d, C-10), 132.3 (d, C-15), 126.7 (d, C-16), 121.5 (d, C-8), 101.5 (s, C-2), 82.9 (d, C-1′), 
77.8 (d, C-3′), 70.2 (d, C-2′), 69.6 (d, C-4′), 67.7 (t, C-5′), 62.5 (d, C-4), 38.0 (t, C-5), 26.8 (q, C-18). 
(+) ESI-MS m/z 517 and 519 (3:1) [M + Na]
+. HR-ESIMS m/z 517.1350 (calcd for C23H27
35ClN2O8Na 
517.1354).  
3.4. Antifungal Activity  
Test isolates were taken from the culture collection at the Operative Unit of Microbiology, Second 
University of Naples and included Candida albicans, C. parapsilosis, C. glabrata, C. tropicalis and 
Fusarium solani. Candida isolates were identified by using using standardized morphological and 
biochemical methods (tube germination, chlamydospora production and API20C) (bioMérieux), while 
F. solani was identified by colonial and microscopic morphologies and stored in sterile distilled water 
at 25 °C. The test isolates were subcultured from stocks in Sabouraud dextrose agar (SDA) (Oxoid) 
and incubated at 30 °C for 48 h for the Candida spp. and 72 h for F. solani. Colonies from cultures of 
Candida species were suspended in 6 mL of phosphate-buffered saline (PBS). The resulting 
suspension was adjusted to the turbidity of a 0.5 McFarland standard at a wavelength of 530 nm. To 
collect conidia following incubation, conidia of the Fusarium were harvested and hyphae were 
removed by filtration through sterile gauze. Conidia were washed with PBS and the suspension was 
adjusted to the turbidity of a 0.15–0.17 McFarland standard at a wavelength of 530 nm. The inoculum 
for the reference macrodilution method was made by a 1:100 dilution in sterile water; this was 
followed by a 1:20 dilution with RPMI-1640 medium (with glutamine, without bicarbonate, and with 
phenol red as a pH indicator) (Sigma) supplemented with 0.2% glucose and buffered to a pH of  
7.0 with 0.165 mol/L MOPS (3-[N-morpholino] propanesulfonic acid) (Sigma). This resulted in a final 
inoculum of 0.5 × 10
3 to 2.5 × 10
3 CFU/mL. In each case, the inoculum size was verified by 
colony counts. 
Stock solutions of aurantosides G–J (2–5) were prepared in sterile de-ionized water. Trays 
containing a 0.1 mL aliquot of the appropriate drug solution (2× final concentration) in each well were 
stored at −70 °C until use. The final concentrations of drug in the wells ranged from 0.008 μg/mL to 
16 μg/mL. The minimal inhibitory concentrations (MICs) were determined in round-bottom 96-well 
microtiter plates using standard broth microdilution protocols described in the CLSI M27-A2 (for yeasts) 
or M38-A (for filamentous fungi) documents. The final inoculum was verified by plating 100 μL of the 
adjusted inoculum onto SDA. Plates were incubated at 30 °C and examined daily for fungal colonies 
for up to 48 h for Candida spp and up to 72 h for F. solani. Two drug-free controls were included in 
each test run: one contained medium alone (sterile control), and the other contained medium plus the 
inoculum (growth control). Each isolate was tested in duplicate in two independent experiments. The 
parameters MIC 50% and MIC 90% (concentrations able to inhibit 50% and 90% of the isolates, 
respectively) were also determined.  Mar. Drugs 2011, 9  
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The minimum fungicidal concentrations (MFCs) were determined for the test compounds only. 
After the MIC was read, 30 μL aliquots of suspension from each well showing total inhibition   
of visible growth were plated onto SDA and incubated at 30 °C. MFCs were read after 48 h   
(for  Candida spp.) or for up to 72 h (for F. solani). The MFC was defined as the lowest drug 
concentration at which no colonies were observed. Each isolate was tested in duplicate in two 
independent experiments. The data were compared using Student’s t-test, and P-values < 0.05 were 
considered significant.  
4. Conclusions 
In conclusion, the chemical investigation of an Indonesian specimen of Theonella swinhoei has 
yielded four aurantosides (G–J), one of which, aurantoside J (5), is a new compound exhibiting the 
unprecedented N-α-glycosidic linkage between the pentose and the tetramate units. The four isolated 
aurantosides have been tested against five fungal strains (four Candida and one Fusarium) responsible 
of invasive infections in immuno-compromised patients. The non-cytotoxic aurantoside I (4) was the 
sole compound to show an excellent potency against all the tested strains, thus disclosing two essential 
requirements to optimize the antifungal activity in this class of compounds: (i) a C18- to C20-polyene 
chain (to minimize the cytotoxic activity against human cell lines); and (ii) a trisaccharide chain 
attached at the tetramate ring.  
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